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Abstract
Background: DNA copy number variations occur within populations and aberrations can cause disease. We sought to 
develop an improved lab-automatable, cost-efficient, accurate platform to profile DNA copy number.
Results: We developed a sequencing-based assay of nuclear, mitochondrial, and telomeric DNA copy number that 
draws on the unbiased nature of next-generation sequencing and incorporates techniques developed for RNA 
expression profiling. To demonstrate this platform, we assayed UMC-11 cells using 5 million 33 nt reads and found 
tremendous copy number variation, including regions of single and homogeneous deletions and amplifications to 29 
copies; 5 times more mitochondria and 4 times less telomeric sequence than a pool of non-diseased, blood-derived 
DNA; and that UMC-11 was derived from a male individual.
Conclusion: The described assay outputs absolute copy number, outputs an error estimate (p-value), and is more 
accurate than array-based platforms at high copy number. The platform enables profiling of mitochondrial levels and 
telomeric length. The assay is lab-automatable and has a genomic resolution and cost that are tunable based on the 
number of sequence reads.
Background
DNA copy number variations occur within populations
and aberrations can cause tumors, be used for drug target
identification, and be used as biomarkers of tumor drug
response. EGFR (epidermal growth factor receptor)
amplification, for instance, is a marker for gefitinib treat-
ment [1] and TYMS (thymidylate synthase) amplification
conveys 5-fluorouracil resistance in colon tumors [2].
The next-generation sequence enables generation of
millions of short sequence tags in a single experiment.
Using DNA as an input, the technology has been used to
resequence entire genomes, including from normal indi-
viduals [3] and from cancerous cells [4], and to rese-
quence targeted genomic regions, such as resequencing
protein coding regions to discover somatic mutations [5].
Alternatively, using RNA as an input, the technology has
been used to profile RNA expression levels, where the
number of sequence reads "tagging" an RNA transcript is
a measure of its expression [6].
Combining these ideas and building on previous meth-
ods [7-10], this report describes the development of a
sequencing-based platform to profile "expression" of
DNA, inputting DNA and analyzing the resultant data
using algorithms previously established for gene expres-
sion profiling. The platform resolution and cost are tun-
able; is lab automatable; can be used for both discovery of
novel and profiling of known DNA copy number varia-
tions; outputs copy number and uncertainty as opposed
to ratios; and can be used to profile mitochondria and
telomeric DNA.
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Results
Application 1: Assaying nuclear genomic copy number
We assayed the genomic copy number in a pool of DNA
derived from blood from non-diseased males; a pool of
DNA derived from blood from non-diseased females; and
DNA from UMC-11 cells, a lung carcinoid-derived cell
line. We generated and sequenced each library, aligned
resultant reads to the genome, and selected reads aligning
to only one genomic location (Methods).
Across chromosome 9, the number of reads from the
male pool mapping to each genomic block is near 250
(Figure 1A, blue). From the female pool, the number of
reads mapping to each block is similarly constant, at
roughly 150 (Figure 1A, green). We tested normalization
by the GC content in each DNA block [9,10]; however, we
found that the relative number of reads mapping to a
block depended more strongly on molecular biology pro-
tocols. Instead, we developed and applied a novel normal-
ization method using the male pool as a reference, and
with this normalization were able to derive the copy
number, upper and lower bounds, and the significance of
any deviation (Methods). In the female DNA pool, the
copy number is two across the entire chromosome, with a
single exception at position ~95 Mb (Figure 1B). Use of a
single reference sample, processed using the same bench
protocol as used for the non-reference samples, therefore
Figure 1 Copy number across chromosome 9 in the male pool, female pool and UMC-11 cells. Top: The number of sequence reads mapping 
to 150 kb windows, stepping at 75 kb. Second: Copy number in the female pool. Blue line, copy number; yellow lines, upper and lower bounds; red 
points, windows with copy number variation (p-value < 0.001). Third: Copy number in the UMC-11 cells. Bottom: Transcripts/genes in the deleted 
region.

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eliminates the need to normalize for GC content and for
sequence uniqueness within each block.
Conversely, UMC-11 cells show dramatic copy number
variations. Before normalization, the number of reads
mapping to each block shows many discrete levels,
including blocks with no reads and blocks with roughly
75, 150, and 225 reads (Figure 1A, red). After normaliza-
tion, these discrete levels map to copy number of zero,
one, two, three, and four (Figure 1C). Intriguingly, the
homozygously deleted region spanning from 21 to 24 Mb
includes the putative tumor suppressor CDKN2A [11]
(Figure 1D).
Across chromosome 12, the female pool has copy num-
ber two across the entire chromosome, as expected (Fig-
ure 2B). The UMC-11 cell line is highly aberrant: copy
number starts at three; is amplified to 9; falls to three; is
amplified up to 29 copies; drops to three; falls to two; has
a small segment at three copies; back to two; and then
back to three. Again intriguingly, the highly amplified
region includes the tumor-associated gene KRAS [12].
This assay provides a genome-wide view of copy num-
ber in a single assay, allowing the full extent of copy num-
ber within a sample to be assessed (Figure 3). While
chromosomes 13, 16, 21, 22, and X in UMC-11 cells show
little disruption, many chromosomes show amazing copy
n u m b e r  v a r i a t i o n .  A l m o s t  5 0  M b  o f  c h r o m o s o m e  5  i s
present at 5 copies. An 80 Mb block of chromosome 6 is
present at one copy. Many changes in copy number occur
close to or across centromeres. We also identify that the
cell line is derived from a male patient as chromosome X
is present at one copy and many reads map to chromo-
some Y.
To validate findings, we assayed copy number with
qPCR at 12 locations (Figure 3, blue boxes; Table 1, Meth-
ods). The five locations predicted to have copy number
two by sequencing indeed had copy number two as mea-
sured by qPCR. Copy number measurements of 1, 3, 4,
and 12 also validated. At high copy number, sequencing
and qPCR measurements were similar: 10 and 11; 26 and
24; 25 and 29, respectively. These results also show high
correspondence with findings from an array-based plat-
form [7] (Table 1, Additional files 1 and 2: Figures S1 and
S2), including the chromosome 9 deletion near 22 Mb
and the small amplification near position 120 Mb. Results
from the highly amplified region of chromosome 12 qual-
itatively agree; however, the array-based method predicts
only 13 copy number in the region where the sequencing
and qPCR assays measure over 25 copy number (Table 1).
Across the entire genome, the array-based data for UMC-
11 cells, downloaded from the Sanger Center and ana-
lyzed with the PICNIC algorithm [13], show high concor-
dance at copy number five and below, but discrepancies
at higher copy number (Figure 4). The array-platform
returns lower copy numbers than found by qPCR and
sequencing, potentially the result of microarray probe
saturation [8].
Application 2: Assaying genetic loci copy number
Conceptually, one can define biological elements in terms
of gene loci rather than genomic blocks, and thus, by
counting the number of reads uniquely mapping to each
locus, generate a gene-copy number table. Here, we
defined locus coordinates as the greater of the transcript
s t a r t - t o - s t o p  s p a n  o r  6 0  k b  c e n t e r e d  o n  t h e  l o c i .  A s
before, we normalized the counts to the reference male
pool, assuming the male pool is diploid across autosomes
and haploid across allosomes.
The loci with the most significant p-values for higher
copy number in the female pool are, not surprisingly,
found on chromosome X (Figure 5A). In each case, this
platform assayed the loci at copy number two in the
female pool and one in the male pool and UMC-11 cells.
The loci with the most significant lower copy number in
UMC-11 cells are in the chromosome 9 deletion (Figure
5B), where the loci show copy number two in the female
pool. The loci with the most significant amplifications are
in the chromosome 12 amplification (Figure 5C), with
copy number at almost 30.
Similarly, biological elements can be defined in terms of
the coordinates of known DNA copy number polymor-
phisms [14]. By counting reads aligning within the coor-
dinates of each established polymorphism, one can
monitor population-variable copy number polymor-
phisms (not shown).
Application 3: Mitochondrial copy number
Biological elements can also be defined as the mitochon-
drial DNA (mtDNA), in which case one assays the num-
ber of mitochondria in the cells. While the counts of
mtDNA within each individual cell will vary, blood-
derived cells on average contain fewer mitochondria rela-
tive to cell lines [15]. From the aligned sequence reads, we
counted and normalized the number of reads aligning to
mtDNA as a measure of the average mtDNA levels within
each sample. Indeed, we found that the UMC-11 cells
contain over 5 times more mitochondria than the blood-
derived male and female pools (Figure 6A).
Application 4: Telomere copy number
Finally, another fascinating biological element that can be
interrogated is telomeric sequence. Telomeres protect the
ends of chromosomes; are on average shorter in cells that
have undergone many divisions, such as older cells,
tumors, and cell lines; and comprise repetitive TTAGGG
motifs [16]. We counted and normalized the number of
sequence reads containing (TTAGGG)4. Strikingly, the
UMC-11 cells do contain significantly fewer telomere-Castle et al. BMC Genomics 2010, 11:244
http://www.biomedcentral.com/1471-2164/11/244
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associated reads than either the female or male pools
(Figure 6B).
Discussion and Conclusions
Assaying DNA copy number by next-generation sequenc-
ing is robust and accurate. The method described here
requires a simple genomic DNA library construction;
returns integer copy number values for homogeneous
cells; and has a large dynamic range. The platform is
unbiased in the sense that genomic targets are not prese-
lected, such as is the case with qPCR and microarrays,
and thus, given a new genome assembly, a new set of copy
number polymorphisms, or a new set of biological DNA
elements, the sequence reads maintain utility through re-
alignment.
O u r  r e s e a r c h  b u i l d s  o n  p r e v i o u s  e f f o r t s .  T h e  ' d i g i t a l
karyotyping' protocol uses restriction enzymes and SAGE
sequencing technology to generate reads that have been
used to measure copy number variation and detect infec-
tious viral DNA[17,18]. Using Illumina deep-sequencing,
fetal aneuploidy was assayed, identifying Down, Edward,
and Patau syndromes based on chromosome-specific tri-
somy [19]. Illumina deep-sequencing has been used to
examine copy number across nuclear chromosomes.
Figure 2 Copy number across chromosome 12, as per Figure 1.

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Figure 3 Genome-wide copy number in the UMC-11 cells. Copy number is assayed in 500 kb windows, stepping at 100 kb. Blocks are assigned 
color based on the nearest integer. Tan regions contain fewer than 50 uniquely aligning reads in the reference sample. Below each chromosome, pink 
marks unsequenced regions and the 12 blue boxes mark the locations assayed by qPCR.

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Campbell et al[7] used paired-end reads from size-
selected libraries to identify genomic structural rear-
rangements and, integrating estimates of copy number
with paired-end reads mapping to distal locations, were
able to identify breakpoint coordinates and novel DNA
sutures. Recently, Chiang et al[8] sequenced a size-
selected library and measured the log-ratio change
between normal and tumor sample pairs across nuclear
chromosomes. They elegantly show trade-off curves
between read number, copy number change, and genomic
resolution and show statistical determination of break-
points. In comparing their results to array-based meth-
ods, they find the sequencing-based platform has a larger
dynamic range. Yoon et al. [10] and Alkan et al. [9] devel-
oped similar methods for use in human resequencing
projects, using over 1 billion reads and 30× genome cov-
erage to identify copy number polymorphisms in disease-
free cells.
The method described here expands on these ground-
breaking studies in several ways. First, our library con-
struction does not include a size selection and is thus lab
automatable. Second, by using a single diploid reference
sample along with a novel normalization algorithm, our
method removes biases inherent in molecular biology
protocols and outputs absolute copy number in addition
to log-ratio values. Third, we defined an uncertainty that
allows us to estimate upper and lower bounds and p-val-
ues for each copy number measurement, both for abso-
lute and relative measurements. Forth, by defining
biological elements as not only nuclear DNA blocks posi-
tioned evenly across the nuclear genome, this platform
enables assaying other biologically meaningful DNA ele-
ments, including gene loci, known copy number poly-
morphisms, mitochondria, and telomeres.
Finally, these results were generated using an Illumina
Genome Analyzer II instrument in June, 2008, with one
sample per lane, resulting in only 3 to 7 million 36 nt
reads per sample. Sequencing instrumentation continues
to improve, allowing more reads at lower costs. As the
resolution of this assay is inversely proportional to the
number of aligned reads, sample multiplexing and
increasing numbers of sequence reads will enable
increased resolution and/or significantly decreased costs.
Methods
Proof of concept of the sequencing-based DNA copy 
number profiling assay
To develop and evaluate a sequencing based platform for
assaying CNV, we prepared genomic DNA libraries from
a pool of DNA derived from blood from non-diseased
males; a pool of DNA derived from blood from non-dis-
eased females; and DNA from the UMC-11 cell line, a
lung carcinoid-derived cell line. DNA was fragmented
using DNase. We did not test whether DNase can shear
heterochromatin sequence such as in centromeres; how-
ever, we used only sequence reads that align uniquely to
the genome and thus would not use sequence reads from
regions of low sequence-complexity. The ends of the frag-
mented DNA were filled in or cleaved to produce blunt
ends. This blunted DNA was ligated to adapters contain-
ing reverse complements on like adapters for suppression
PCR as well as priming sites for a set of universal PCR
primers and the Illumina sequencing primer. These
"DNA Libraries" were then amplified using standard PCR
conditions. We did not use size-selection after fragmen-
tation, allowing lab-automation of library construction.
We sequenced libraries in the Illumina Genome Ana-
lyzer II sequencer, generating 6,744,152 (male pool),
3,283,370 (female pool), and 5,204,934 (UMC-11) reads
Figure 4 Comparison between UMC-11 copy number from se-
quencing platform with that from Affymetrix SNP6 arrays ana-
lyzed using the Sanger PICNIC algorithm.
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(Table 2) (NCBI GEO accession GSE21159) Each 36 nt
read contained a 3 nt molecular barcode for potential
sample multiplexing which was trimmed before align-
ment.
Genomic alignment
The resultant sequence reads were computationally
aligned to the genome using the algorithm BWA [20]. We
used only reads aligning to the genome with the highest
(least ambiguous) score, minimizing incorrect mappings
such as those from the female pool mapping to the Y
chromosome. A shortcoming of the use of uniquely align-
ing reads is that reads aligning to sequence-identical seg-
mental duplications within the HG18 genome will be
discarded and these regions not monitored. Between 92%
and 93% of the reads aligned to the genome, with
between 63% and 65% aligning unambiguously (Table 2).
For each unambiguously aligned read, we recorded the
chromosome and 5' coordinate.
We computationally tested use of different read
lengths. Shorter reads are more likely to align ambigu-
ously whereas longer reads are more likely to align to a
unique genomic location. We computationally generated
all oligos (tiles) from the human genome at lengths from
20 nt to 200 nt. We aligned all to the genome and, for
each tile length, determined the fraction of the reads that
aligned to only one location (Figure 7). Seven percent of
the human genome remains undetermined, containing
repeat and low-complexity sequence patterns, e.g. cen-
tromeres.
Only 26% of the 20 nt tiles align uniquely, increasing to
65% at 25 nt, and to 70% at 30 nt, and smoothly increas-
ing to 90% at 200 nt. A fundamental shift occurs between
20 and 25 nt: genome uniqueness changes from majority
ambiguous to majority unambiguous. The 33 nt length
(36 nt minus the 3 nt barcode) used in the study here rep-
resents an effective trade-off between sequencing costs
(time and money) and read uniqueness.
Counting & uncertainty
We selected biological elements for examination, such as
DNA windows. For each window, we counted the number
of reads aligning within the window. We compared the
number to that found in a diploid reference sample. We
used the DNA pooled from non-diseased males as a ref-
erence as the DNA should be diploid across autosomes
and represent all chromosomes, including chromosome
Y.
We defined an error model for a measurement "x" as a
Poisson term from counting statistics:
With this error model, a block with 100 reads would
have an uncertainty of ± 10. This error model reflects
sampling uncertainty but neither biological or operator
variability.
We used a uniform window size across the genome;
however, a variable window size could be selected. The
selected window size should reflect the total number of
uniquely aligned reads available, the desired sensitivity/
significance, and the sample cell-to-cell genomic hetero-
geneity. Here, we assumed that the cellular DNA was
homogeneous and wished to have the power to distin-
guish copy number 3 from 2 at a p-value better than 0.001
assuming the described error model. This equates to 110
reads per genomic block. As we had 3.3 million reads
from the female blood pool, of which 2.1 million uniquely
aligned to the genome, and given the human genome of
s = x
Table 1: Validation of sequencing copy number assayed by qPCR.
Chromosome Coordinate qPCR Sequencing Array
2 124,585,349 2 2 2
2 168,899,639 3 3 3
2 184,059,790 4 4 4
6 39,100,000 11 10 7
6 87,009,800 1 1 1
12 16,995,694 24 26 13
12 21,762,192 12 12 8
12 25,206,027 29 25 11
13 60,000,100 2 2 2
14 60,000,100 2 2 2
15 60,000,100 2 2 2
16 60,000,100 2 2 2
Values are rounded to the nearest integer.Castle et al. BMC Genomics 2010, 11:244
http://www.biomedcentral.com/1471-2164/11/244
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Figure 5 Gene-centric copy number. Top: the six genes with the most significant amplification in the female pool. Middle: the six genes with the 
most significant decreased copy number in the UMC-11 cells. Bottom: the six genes with the most significant amplification in the UMC-11 cells. The 
male pool is assumed to be diploid (autosomes) and haploid (allosomes).Castle et al. BMC Genomics 2010, 11:244
http://www.biomedcentral.com/1471-2164/11/244
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3.1 billion base pairs, this results in a block size of 164 kb.
We rounded to 150 kb blocks.
Normalization
We normalized reads to account for the differing num-
bers of reads per sample and to determine absolute copy
number. We found that the relative number of reads map-
ping to a DNA block depended on the molecular biology
protocol used, thus necessitating use of a empirical nor-
malization rather than simply a measure such as GC con-
tent. We used a male pool as a reference, and with this
normalization were able to derive the copy number,
upper and lower bounds, and the significance of any vari-
ation.
We counted the reads mapping to each 150 kb block
from the male and female pools and generated a ratio,
female-to-male, for each block. There were roughly twice
the number of reads for the male sample (Table 1), and
thus the distribution of ratios peaks near 0.5 (Figure 8,
top left). Normalizing by the number of aligned reads
from the female and male samples results in a distribu-
tion peaked near one, as expected for samples with simi-
lar ploidy, and copy number two, assuming the male
sample pool is diploid across autosomes (Figure 8, lower
left).
The distribution of UMC-11 to male ratios after nor-
malization by the number of reads shows multiple peaks,
none of which are centered at an integer (Figure 8, middle
right). We tried using the ratios to determine the normal-
ization: using the ratio mean or the median failed to cen-
ter a distribution peak at an integer . However , we were
able to normalize the counts based on the mode of the
ratio distribution across autosomes. After normalization
by the ratio model, we find that the three peaks in the
ratio distribution from the UMC-11 cell line are regions
with one, two, and three copy number (Figure 8, lower
right).
Comparisons between samples
To compare CNV between samples, we calculated the
significance of a difference using a t-test and p-value
based on the normalized counts and normalized uncer-
tainties. For each DNA element, the assay thus returns
the absolute copy number, uncertainty, upper and lower
bounds, and a p-value representing the significance of a
measured difference.
Figure 6 Mitochondria and telomere copy number.

Table 2: Sequencing reads (33 nt) and alignments.
Sample Reads Aligned to 
genome
% Unambiguous 
match
%
Female pool 3,283,370 3,038,662 93% 2,061,012 63%
Male pool 6,744,152 6,193,928 92% 4,372,811 65%
UMC-11 5,204,934 4,768,159 92% 3,313,093 64%
Figure 7 Genome uniqueness at small scale lengths. At each 
length scale, all oligos were aligned to the genome and unambiguous-
ly aligned reads were counted. The y-axis includes unsequenced re-
gions (7%).
Castle et al. BMC Genomics 2010, 11:244
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Figure 8 Normalization allows absolute copy number estimate after normalization, assuming the male pool is diploid across all auto-
somes. Left: female pool (blue). Right: UMC-11 (red). A and D: genome-wide distribution of the ratios of the number of reads aligning in each 150 kb 
window relative to the number in the same window from the male pool. B and E: counts are normalized by the total number of unambiguously 
aligned reads from each sample. C and F: counts are normalized by the mode from the distribution in B and E. Copy number of 1, 2, and 3 can be 
clearly seen in the UMC-11 sample.

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Validation with qPCR
We used qPCR (Taqman) to assay DNA copy number in
UMC-11 cells. TaqMan primer-probe reagents were
obtained through the Applied Biosystems Assays-by-
Design custom assay service (Foster City, CA) and
designed to fall outside of repeat regions.
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Additional file 1 Figure S1. UMC-11 chromosome 9 copy number from 
the deep-sequencing platform (top) and Affymetrix SNP6 arrays and the 
Sanger Picnic algorithm [13] (bottom, green line).
Additional file 2 Figure S2. UMC-11 chromosome 12 copy number from 
the deep-sequencing platform (top) and Affymetrix SNP6 arrays with the 
Sanger Picnic algorithm [13] (bottom, green line).
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